ST段抬高型心肌梗死的预防性经皮冠状动脉介入治疗——随机试验的首要地位
Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction - The Primacy of Randomised Trials.
作者信息
Wald David S, Bestwick Jonathan P
机构信息
Professor of Cardiology.
Lecturer in Medical Statistics, Wolfson Institute of Preventive Medicine, London, UK.
出版信息
Interv Cardiol. 2015 Mar;10(1):32-34. doi: 10.15420/icr.2015.10.1.32.
Abstract
Randomised trials show a benefit of preventive (non-infarct artery) percutaneous coronary intervention in patients with acute ST elevation myocardial infarction, but non-randomised studies do not. The evidence on each is quantified and assessed. The primacy of randomised trials reveals the danger of using non-randomised studies that can, as in this case, give the wrong answer.
摘要
随机试验表明，对于急性ST段抬高型心肌梗死患者，预防性（非梗死相关动脉）经皮冠状动脉介入治疗有益，但非随机研究则未显示出此益处。对二者的证据进行了量化和评估。随机试验的首要地位揭示了使用非随机研究的风险，就像在这个案例中，非随机研究可能会给出错误答案。
相似文献
1
Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction - The Primacy of Randomised Trials.ST段抬高型心肌梗死的预防性经皮冠状动脉介入治疗——随机试验的首要地位
Interv Cardiol. 2015 Mar;10(1):32-34. doi: 10.15420/icr.2015.10.1.32.
2
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.经皮介入治疗 ST 段抬高型心肌梗死合并慢性完全闭塞病变患者：EXPLORE 试验。
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.
3
Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.在多支冠状动脉疾病的ST段抬高型心肌梗死患者中，非梗死相关动脉严重病变管理中血管造影引导下多支血管经皮冠状动脉介入治疗与缺血引导下经皮冠状动脉介入治疗及药物治疗的比较
Crit Pathw Cardiol. 2018 Jun;17(2):77-82. doi: 10.1097/HPC.0000000000000144.
4
Early occlusion of the non-infarct-related coronary artery following successful primary percutaneous coronary intervention in ST-elevation myocardial infarction.ST段抬高型心肌梗死患者成功进行直接经皮冠状动脉介入治疗后非梗死相关冠状动脉的早期闭塞
Postepy Kardiol Interwencyjnej. 2015;11(2):136-40. doi: 10.5114/pwki.2015.52287. Epub 2015 Jun 22.
5
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性：EARLY-MYO 试验（阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较）。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
6
Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.ST 段抬高型心肌梗死合并心原性休克患者的多支血管经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Feb 27;71(8):844-856. doi: 10.1016/j.jacc.2017.12.028.
7
Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.参与国际前瞻性随机试验“替格瑞洛在导管室或救护车上用于新发性ST段抬高型心肌梗死开通冠状动脉（ATLANTIC）试验”的ST段抬高型心肌梗死患者的性别与短期预后之间的关联：一项预先设定的分析。
BMJ Open. 2017 Sep 21;7(9):e015241. doi: 10.1136/bmjopen-2016-015241.
8
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.ST 段抬高型心肌梗死伴多支血管病变患者完全血运重建与罪犯病变血运重建的比较：DANAMI-3-PRIMULTI 心脏磁共振子研究。
JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.
9
Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.ST段抬高型心肌梗死中罪犯血管与多支血管冠状动脉介入治疗：随机试验的荟萃分析
Coron Artery Dis. 2018 Mar;29(2):151-160. doi: 10.1097/MCA.0000000000000578.
10
Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).症状发作后极早期行院前启动的辅助经皮冠状动脉介入治疗与直接经皮冠状动脉介入治疗治疗急性心肌梗死的随机比较：LIPSIA-STEMI 试验（莱比锡即刻院前辅助 ST 段抬高型心肌梗死血管成形术）
JACC Cardiovasc Interv. 2011 Jun;4(6):605-14. doi: 10.1016/j.jcin.2011.01.013.
引用本文的文献
1
Preventive percutaneous coronary intervention and aspiration thrombectomy-updates in the management of ST-elevation myocardial infarction.预防性经皮冠状动脉介入治疗和血栓抽吸术——ST段抬高型心肌梗死管理的最新进展
J Thorac Dis. 2016 Aug;8(8):1908-12. doi: 10.21037/jtd.2016.07.73.
本文引用的文献
1
Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.ST 段抬高型心肌梗死患者中非梗死相关冠状动脉疾病的范围、部位和临床意义。
JAMA. 2014 Nov 19;312(19):2019-27. doi: 10.1001/jama.2014.15095.
2
Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.ST段抬高型心肌梗死合并多支血管病变患者在直接经皮冠状动脉介入治疗时罪犯血管与多支血管干预：伦敦3984例患者的真实世界分析
Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):936-43. doi: 10.1161/CIRCOUTCOMES.114.001194. Epub 2014 Nov 4.
3
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
4
Randomized trial of preventive angioplasty in myocardial infarction.随机对照试验预防心肌梗死的血管成形术。
N Engl J Med. 2013 Sep 19;369(12):1115-23. doi: 10.1056/NEJMoa1305520. Epub 2013 Sep 1.
5
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2013 Jan 29;127(4):529-55. doi: 10.1161/CIR.0b013e3182742c84. Epub 2012 Dec 17.
6
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.ST段抬高型急性心肌梗死患者管理的欧洲心脏病学会指南
Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.
7
Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry).多支冠状动脉疾病及非梗死相关动脉血运重建对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者预后的影响（来自欧洲转运注册研究）
Am J Cardiol. 2010 Aug 1;106(3):342-7. doi: 10.1016/j.amjcard.2010.03.029. Epub 2010 Jun 18.
8
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.急性 ST 段抬高型心肌梗死时非罪犯血管经皮冠状动脉介入治疗：来自 APEX-AMI 试验的观察。
Eur Heart J. 2010 Jul;31(14):1701-7. doi: 10.1093/eurheartj/ehq129. Epub 2010 Jun 8.
9
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.罪犯血管经皮冠状动脉介入治疗与多血管和分期经皮冠状动脉介入治疗 ST 段抬高型心肌梗死合并多血管病变患者。
JACC Cardiovasc Interv. 2010 Jan;3(1):22-31. doi: 10.1016/j.jcin.2009.10.017.
10
A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.随机化研究显示 ST 段抬高型心肌梗死患者罪犯血管与多支血管血运重建的比较：长期随访期间主要不良心脏事件。
Heart. 2010 May;96(9):662-7. doi: 10.1136/hrt.2009.177162. Epub 2009 Sep 23.
Zotero 插件